Paper Details
- Home
- Paper Details
Original Abstract of the Article :
INTRODUCTION: The use of 6-mercaptopurine (6MP) and its prodrug azathioprine (AZA) for inflammatory bowel disease (IBD) has increased in recent years. The pharmacology, patient response in controlled trials, new formulations and routes of administration and safety for these agents are reviewed. PHA...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1080/003655298750027290
データ提供:米国国立医学図書館(NLM)
Azathioprine: A Powerful Tool in the Management of Inflammatory Bowel Disease
This review explores the use of azathioprine (AZA) in the treatment of inflammatory bowel disease (IBD). It's like a journey through a medical library, seeking to understand the role of this powerful medication in managing this chronic condition. The authors delve into the pharmacology, clinical response, and safety of AZA in IBD patients.
Azathioprine's Effectiveness in IBD: A Comprehensive Overview
This review provides a comprehensive overview of AZA's effectiveness in various IBD indications, including inflammatory Crohn's disease, fistulizing Crohn's disease, and ulcerative colitis. It's like a detailed map of the medical landscape, guiding clinicians towards informed decisions regarding AZA use in IBD management. The review highlights the potential benefits and limitations of AZA therapy, providing valuable information for clinicians and patients.
Navigating the Landscape of IBD Treatment: Understanding the Risks and Benefits of Azathioprine
This review emphasizes the importance of understanding the potential risks and benefits of AZA therapy in IBD. It's like navigating a complex desert landscape, being aware of both the challenges and opportunities. The authors provide information on potential side effects, such as pancreatitis, leukopenia, and infection, as well as the potential for improved disease control and reduced steroid dependence. This comprehensive overview empowers clinicians to make informed decisions about AZA therapy, considering the individual needs and circumstances of their patients.
Dr.Camel's Conclusion
This review offers a valuable resource for understanding the role of AZA in IBD management. It's a testament to the ongoing efforts in medical research to find effective and safe treatment options for chronic diseases. By being informed about the potential benefits and risks of AZA therapy, clinicians can provide optimal care and improve the lives of individuals with IBD.
Date :
- Date Completed 1998-05-14
- Date Revised 2019-09-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.